Clinical Trials Directory

Trials / Sponsors / Matinas BioPharma Nanotechnologies, Inc.

Matinas BioPharma Nanotechnologies, Inc.

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
UnknownEncochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3
Cryptococcal Meningitis
Phase 32023-01-01
CompletedPharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertrigly
Hypertriglyceridemia
Phase 22020-06-03
WithdrawnEfficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvo
Vulvovaginal Candidiases, Yeast Infection, Vulvovaginitis
Phase 22019-12-01
CompletedEncochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
Cryptococcal Meningitis
Phase 1 / Phase 22019-10-24
WithdrawnSafety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Underg
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 22019-08-01
WithdrawnEfficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection
Cryptococcal Infections
Phase 1 / Phase 22018-10-01
CompletedSafety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candid
Vulvovaginitis, Yeast Infection, Yeast Infection Vaginal
Phase 22016-11-01
CompletedCAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Candidiasis, Chronic Mucocutaneous
Phase 22016-09-27